title: Response.
authors.affiliation: Hamilton, Ont.
authors.forename: James
authors.initials: J
authors.lastname: Douketis
authors.affiliation: Hamilton, Ont.
authors.forename: John
authors.initials: J
authors.lastname: Eikelboom
authors.affiliation: Hamilton, Ont.
authors.forename: Aaron
authors.initials: A
authors.lastname: Liew
authors.affiliation: Toronto, Ont.
authors.forename: Alan David
authors.initials: AD
authors.lastname: Bell
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D005194:Family Practice; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*; D013876:Thiophenes / Q000627:therapeutic use*; D054556:Venous Thromboembolism / Q000188:drug therapy*; D015091:beta-Alanine / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011720:Pyrazoles; D011728:Pyridones; D013876:Thiophenes; D015091:beta-Alanine